Primary biliary cirrhosis in Taiwan

Area of Science:

• Hepatology
• Autoimmune Diseases

Background:

• Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease.
• Understanding the epidemiology and clinical presentation of PBC in diverse populations is crucial for timely diagnosis and management.

Purpose of the Study:

• To describe the clinical characteristics, serological markers, and outcomes of primary biliary cirrhosis patients in Taiwan.
• To compare the presentation of PBC in Taiwan with that reported in Western countries.

Main Methods:

• Retrospective analysis of 30 consecutive primary biliary cirrhosis patients diagnosed in Taiwan.
• Assessment of clinical manifestations, laboratory findings (including antimitochondrial antibodies and antinuclear antibodies), and associated diseases.
• Evaluation of patient outcomes during a mean follow-up period of 23.6 months.

Main Results:

• The study included 30 patients (27 female, median age 54.5 years at onset).
• Most patients presented with advanced disease, with ascites (30%) and esophageal varices (43%) being common.
• Elevated alkaline phosphatase, alanine aminotransferase, and IgM were frequent; 93% tested positive for antimitochondrial antibodies.
• Hepatitis B surface antigen positivity was low (3.8%) compared to the general population.
• Associated conditions included systemic lupus erythematosus, scleroderma, lymphoma, and hepatocellular carcinoma.

Conclusions:

• Clinical manifestations of PBC in Taiwan are largely similar to Western cohorts.
• A significant proportion of Taiwanese PBC patients present at later stages of the disease.
• The low prevalence of Hepatitis B surface antigen suggests it is not a major factor in Taiwanese PBC cases.